Skip to main content
Signal8

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

$JAGXPress releaseApr 27, 2026, 9:00 AM ETRead the release

Jaguar Health received an extension from the Nasdaq Hearings Panel until May 15, 2026, to regain compliance with the $1.00 minimum bid price requirement. To ensure the stock meets this threshold, the company will effect a 1-for-35 reverse stock split effective April 30, 2026, with shares trading on a split-adjusted basis at the market open.

Key figures

Split ratio
1-for-35
Effective date
April 30, 2026
Extension date
May 15, 2026

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    JAGX: Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split — AI Analysis | Signal8